Profil
Shoba Murali is the founder.
She founded The UCAN Co. in 2008 and currently holds the title of President & Director.
Ms. Murali also served as Chairman at GlyGenix Therapeutics, Inc. in a former position.
Aktive Positionen von Shoba Murali
| Unternehmen | Position | Beginn |
|---|---|---|
The UCAN Co.
 The UCAN Co. Food RetailRetail Trade The UCAN Co. manufactures energy drink for sports nutrition. The company is headquartered in Woodbridge, CT. | Gründer | 17.01.2008 |
Ehemalige bekannte Positionen von Shoba Murali
| Unternehmen | Position | Ende |
|---|---|---|
GlyGenix Therapeutics, Inc.
 GlyGenix Therapeutics, Inc. BiotechnologyHealth Technology GlyGenix Therapeutics, Inc. focuses on treating and curing Glycogen storage diseases. The firm’s services include development of nucleic acid molecules that compensate or correct the genetic defects that cause Glycogen storage disease type 1a. The company was founded by David Feldman and Peter Kaufman in 2006 and is headquartered in Woodbridge, CT. | Vorsitzender | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
GlyGenix Therapeutics, Inc.
GlyGenix Therapeutics, Inc. BiotechnologyHealth Technology GlyGenix Therapeutics, Inc. focuses on treating and curing Glycogen storage diseases. The firm’s services include development of nucleic acid molecules that compensate or correct the genetic defects that cause Glycogen storage disease type 1a. The company was founded by David Feldman and Peter Kaufman in 2006 and is headquartered in Woodbridge, CT. | Health Technology |
The UCAN Co.
The UCAN Co. Food RetailRetail Trade The UCAN Co. manufactures energy drink for sports nutrition. The company is headquartered in Woodbridge, CT. | Retail Trade |
